An Introduction to Toxicology and Its Methodologies

Computational Toxicology: Risk Assessment for Pharmaceutical and Environmental Chemicals

Volumn , Issue , 2006, Pages 1-20

  Combs, Alan B ^a   Acosta, Daniel ^b  

^a The Center for Molecular Carcinogenesis and Toxicology   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

In vitro methodologies for fields; Safety screening tools and predictive toxicology; Toxicology and methodologies

Indexed keywords

EID: 84889616980     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470145890.ch1     Document Type: Chapter

References (49)

1. Osborne G, Gruninger S. 2001.
2. Borzelleca JF. Profiles in toxicology-Paracelsus: Herald of modern toxicology. Toxicol Sci 2000;53:2-4.
3. Malarkey DE, Maronpot RR. Carcinogenesis. In: Wexler P, Anderson BD, de Peyster A, Gad SC, Hakkinen PJ, Kamrin MA, Locey BJ, Mehendale HM, Pope CN, Shugart LR, editors, Encyclopedia of toxicology, 2nd Ed., Vol. 1. Oxford: Elsevier Ltd., 2005. p. 445-66.
4. Gad SC. Genotoxicity. In: Gad SC, editor, Drug safety evaluation. New York: Wiley, 2002. p. 176-236.
5. Gad SC. Developmental and reproductive toxicity testing. In: Gad SC, editor, Drug safety evaluation, New York: Wiley, 2002. p. 258-96.
6. Anonymous. Benzene material safety data sheet. ScienceLab.com .
7. Bakhshi S, Baynes R. Aplastic anemia. eMedicine on-line 2006 .
8. Sturtevant JM, Pillans PI, Mackenzie F, Gibbs HH. Heparin-induced thrombocytopenia: Recent experience in a large teaching hospital. Intern Med J 2006;36:431-6.
9. Haschek WM, Rousseaux CG, editors. Immune system. In: Fundamentals of toxicologic pathology. New York: Academic Press, 1998. p. 233-72.
10. Wood AJJ, Darbyshire J. Injury to research volunteers-The clinical-research nightmare. N Eng J Med 2006;354:1869-71.
11. Marshall E. Violent reaction to monoclonal antibody therapy remains a mystery. Science 2006;311:1688-9.
12. Haschek WM, Rousseaux CG, editors. Hepatobiliary system. In: Fundamentals of toxicologic pathology. New York: Academic Press, 1998. p. 127-51.
13. Haschek WM, Rousseaux CG, editors. The kidney. In: Fundamentals of toxicologic pathology. New York: Academic Press, 1998. p. 153-93.
14. Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Eng J Med 2006;354:731-9.
15. Monks TJ, Lau SS. Toxicology of quinone-thioethers. Crit Rev Toxicol 1992;22:243-70.
16. Haschek WM, Rousseaux CG, editors. Respiratory system. In: Fundamentals of toxicologic pathology. New York: Academic Press, 1998. p. 91-126.
17. Haschek WM, Rousseaux CG, editors. Nervous system. In: Fundamentals of toxicologic pathology. New York: Academic Press, 1998. p. 355-93.
18. Combs AB, Ramos K, Acosta D. Cardiovascular toxicity. In: Hodgson E, Smart RC, editors, Introduction to biochemical toxicology, 3rd Ed. New York: Wiley-Interscience, 2001. p. 673-96.
19. Pan SJ, Combs AB. Emetine inhibits glycolysis in isolated, perfused rat hearts. Cardiovasc Toxicol 2003;03:311-18.
20. Fermini B, Fossa AA. The impact of drug-induced QT interval prolongation on drug discovery and development. Nat Rev Drug Discov 2003;2:439-47.
21. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Eng J Med 1994;331:1272-85.
22. Parrillo SJ, Parrillo CV. Stevens-Johnson syndrome. eMedicine online 2006: .
23. Cohen C. The case for the use of animals in biomedical research. N Eng J Med 1986;315:865-69.
24. Horton L. The enduring animal Issue. J Natl Cancer Inst 1989;81:736-43.
25. Anonymous. The three "R's" of Russel & Burch, 1959. 3R-INFO-BULLETIN 7-March 1996: .
26. Anonymous. Blue blood, The horseshoe crab, The history of Limulus and Endotoxin. . Site verified as of June 2006.
27. O'Donnell K. Animal rights myths, FAQ v1.3 2000. . Site verified as of June 2006.
28. Gad SC. In vitro toxicology. London: Taylor and Francis, 2000.
29. Gossel TA, Bricker JD. Metals. In: Principles of clinical toxicology, 3rd Ed. New York: Raven Press, 1994, p. 179-214.
30. Kehrer JP. Free radicals as mediators of tissue injury and disease. Critical Rev Toxicol 1993;23:21-48.
31. Sabbah HN, Sharov VG. Apoptosis in heart failure. Cardiovas Dis 1998;40:549-62.
32. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:248-53.
33. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000;287:1056-60.
34. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.
35. Carreyrou J. Fosamax drug could become next merck woe. Wall Street Journal Online: April 12, 2006: p. B1 .
36. Anonymous. .
37. Anonymous. .
38. Anonymous. .
39. Liu ET, Karuturi KR. Microarrays and clinical investigations. N Eng J Med 2004;350:1595-7.
40. Evans WE, Guy RK. Gene expression as a drug discovery tool. Nat Genet 2004;36:214-5.
41. Anonymous. .
42. Yang Y, Abel SJ, Ciurlionis R, Waring JF. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds. Pharmacogenomics 2006;7:177-86.
43. Fielden MR, Kolaja KL. The state-of-the-art in predictive toxicogenomics. Curr Opin Drug Discov Devel 2006;9:84-91.
44. Borlak J, Drewes J, Hofmann K, Bosio A. Toxicogenomics applied to in vitro toxicology: A cDNA-array based gene expression and protein activity study in human hepatocyte cultures upon treatment with Aroclor 1254. Toxicol In Vitro 2005;20:736-47.
45. Salter AH, Nilsson KC. Informatics and multivariate analysis of toxicogenomics data. Curr Opin Drug Discov Devel 2003;6:117-22.
46. Benfenati E, Gini G. Computational predictive programs (expert systems) in toxicology. Toxicology 1997;119:213-25.
47. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20-9.
48. Anonymous. .
49. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 1949;96:99-113.